Skip to main content
Screener/Healthcare/Biotechnology

GYRE — Gyre Therapeutics, Inc.

NASDAQ
$6.15+0.02 (+0.33%)
Small CapUnder $10HealthcareHigh Beta
$5.44
$9.42
$6.10
$6.25
EPS (TTM)$-0.08
P/E Ratio359.56
Dividend Yield—
Market Cap$606.4M
Volume41K
Prev Close$6.13
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$22.5M-$8.6M$-0.1094.6%-38.3%
Q4 '25$37.2M-$1.7M$-0.0295.3%-4.6%
Q3 '25$30.6M$3.6M$0.0394.7%11.8%
Q2 '25$26.8M$442K$0.0095.7%1.7%
Q1 '25$22.1M$2.7M$0.0095.9%12.2%
Q4 '24$27.9M-$99K$-0.1695.8%-0.4%
Q3 '24$25.5M$1.1M$0.0596.2%4.4%
Q2 '24$25.2M$3.5M$0.0396.9%14.0%
Get Your Daily Market Recap